Latest filing published 21 Feb 2020 for NextCure, Inc., €15k.
Linda Liu is a declared insider of NextCure, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated 27 November 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 21 February 2020, reports an option exercise of €15k in NextCure, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.